Back to Search
Start Over
Biological Effects of Morpholin-4-Ium 4 Methoxyphenyl (Morpholino) Phosphinodithioate and Other Phosphorothioate-Based Hydrogen Sulfide Donors.
- Source :
-
Antioxidants & redox signaling [Antioxid Redox Signal] 2020 Jan 10; Vol. 32 (2), pp. 145-158. - Publication Year :
- 2020
-
Abstract
- Significance: Hydrogen sulfide (H <subscript>2</subscript> S) is regarded as the third gasotransmitter along with nitric oxide and carbon monoxide. Extensive studies have demonstrated a variety of biological roles for H <subscript>2</subscript> S in neurophysiology, cardiovascular disease, endocrine regulation, and other physiological and pathological processes. Recent Advances: Novel H <subscript>2</subscript> S donors have proved useful in understanding the biological functions of H <subscript>2</subscript> S, with morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (GYY4137) being one of the most common pharmacological tools used. One advantage of GYY4137 over sulfide salts is its ability to release H <subscript>2</subscript> S in a slow and sustained manner akin to endogenous H <subscript>2</subscript> S production, rather than the delivery of H <subscript>2</subscript> S as a single concentrated burst. Critical Issues: Here, we summarize recent progress made in the characterization of the biological activities and pharmacological effects of GYY4137 in a range of in vitro and in vivo systems. Recent developments in the structural modification of GYY4137 to generate new compounds and their biological effects are also discussed. Future Directions: Slow-releasing H <subscript>2</subscript> S donor, GYY4137, and other phosphorothioate-based H <subscript>2</subscript> S donors are potent tools to study the biological functions of H <subscript>2</subscript> S. Despite recent progress, more work needs to be performed on these new compounds to unravel the mechanisms behind H <subscript>2</subscript> S release and pace of its discharge, as well as to define the effects of by-products of donors after H <subscript>2</subscript> S liberation. This will not only lead to better in-depth understanding of the biological effects of H <subscript>2</subscript> S but will also shed light on the future development of a new class of therapeutic agents with potential to treat a wide range of human diseases.
- Subjects :
- Animals
Humans
Molecular Structure
Morpholines chemistry
Organothiophosphorus Compounds chemistry
Phosphorothioate Oligonucleotides chemistry
Structure-Activity Relationship
Hydrogen Sulfide chemistry
Morpholines pharmacology
Organothiophosphorus Compounds pharmacology
Phosphorothioate Oligonucleotides pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1557-7716
- Volume :
- 32
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Antioxidants & redox signaling
- Publication Type :
- Academic Journal
- Accession number :
- 31642346
- Full Text :
- https://doi.org/10.1089/ars.2019.7896